3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Recruiting
1
Not yet recruiting
1
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Colorectal Neoplasms
17
Breast Neoplasms
14
Rectal Neoplasms
13
Nasopharyngeal Carcinoma
8
Stomach Neoplasms
5
Triple Negative Breast Neoplasms
3
Colonic Neoplasms
3
Cholangiocarcinoma
3
Carcinoma, Hepatocellular
3
Biliary Tract Neoplasms
3
Adenocarcinoma
3
Recurrence
2
Pancreatic Neoplasms
2
HER2-positive Gastric Cancer
2
Carcinoma, Non-Small-Cell Lung
2
Spinocerebellar Degenerations
1
Rectal Neoplasms Malignant
1
Rectal Cancer Patients
1
Preventive Effect of Quintuple Therapy on Metachronous Liver Metastases in Patients With Colorectal Cancer
1
Pathologic Complete Response
1
Pancreatic Cancer Resectable
1
Pancreatic Cancer Non-resectable
1
Neoplasm Metastasis
1
Nasopharyngeal Neoplasms
1
Nasopharyngeal Cancinoma (NPC)
1
Mouth Neoplasms
1
Metastatic Breast Cancer in the Brain
1
MSI-H Colorectal Cancer
1
Locally Advanced Rectal Cancer (LARC)
1
Locally Advanced Rectal Cancer
1
Interventions
venetoclax
1
tegafur-gimeracil-oteracil
1
tagraxofusp
1
Surgical Procedures, Operative
1
Radiation
1
Oxaliplatin
1
Observation
1
Neoadjuvant Therapy
1
Magnetic Resonance Imaging
1
Leucovorin
1
Irinotecan
1
Induction Chemotherapy
1
Immunotherapy
1
Immune Checkpoint Inhibitors
1
Folfox protocol
1
Fluorouracil
1
FOLFOXIRI protocol
1
Endoscopy
1
Drug Therapy
1
Colonoscopy
1
Chemoradiotherapy
1
Carboplatin
1
Capecitabine
1
130-nm albumin-bound paclitaxel
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Not yet recruiting
×
Pathologic Complete Response
×
Capecitabine
×
Clear all
NCT07472868
2026-03-16
MEND-IT II
Catharina Ziekenhuis Eindhoven
Phase 3
Not yet recruiting
394 enrolled